<DOC>
	<DOC>NCT01113138</DOC>
	<brief_summary>The present study is part of a project titled 'Magnesium in asthma and chronic obstructive pulmonary disease'. The hypothesis of the main project is that daily magnesium supplement will benefit patients with asthma and chronic obstructive pulmonary disease. The aim of this part of the project is to study the pharmacokinetics of the following two magnesium supplements: - Mablet (dietary supplement) - Magnesium Sulfate (solution for infusion)</brief_summary>
	<brief_title>Study of the Metabolism of Two Magnesium Supplements in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>Healthy volunteers. Smokers, Using pharmaceuticals/supplements, Vegans/vegetarians, Major changes in eating habits within one week prior to study start.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Clearance</keyword>
	<keyword>Half-life</keyword>
	<keyword>Absorption fraction</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>